Nature Acceptance Rate: Less Than 8% and What That Actually Means
Senior Researcher, Oncology & Cell Biology
Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.
Is Nature realistic for your manuscript?
Check scope, common rejection reasons, and what it takes to get past desk review.
Nature accepts fewer than 8% of submissions. It's the most recognized scientific journal in the world, and its editorial bar is calibrated accordingly: not "excellent science," but "science that changes how the field thinks." Here's what the numbers actually mean and where most papers fail.
The Numbers
Metric | Value |
|---|---|
Impact Factor | 48.5 (2024) |
Acceptance Rate | <8% |
Annual Submissions | ~10,000 |
Published Papers | ~800/year |
Desk Rejection Rate | ~90% |
Acceptance After Review | ~40-50% |
Time to Desk Decision | ~7 days median |
Time to First Decision (with review) | 2-4 weeks |
Publisher | Springer Nature |
The 90% Desk Rejection Rate
This is the number that matters most. Nine out of ten papers submitted to Nature never reach a reviewer. The editors make this decision in a median of 7 days.
What editors are looking for at the desk:
- Cross-disciplinary significance. Would scientists outside your specific subfield find this important? Would it be discussed across departments? If only specialists in your exact area would care, Nature is the wrong target.
- Conceptual advance. Does this change how scientists think about a question, or does it add data points to an existing framework? Nature wants the former.
- Broad accessibility. Can the paper be written so that an educated non-specialist understands why it matters? Nature's readership spans all sciences.
- Timeliness. Is this topic of current interest? Does it address a question the scientific community is actively debating?
What gets desk rejected:
- Technically flawless papers that are incremental rather than conceptual
- Deep mechanistic studies that only specialists can appreciate (these belong in Cell)
- Work that's excellent but too narrow for a general audience
- Confirmation of existing theories without new insight
- Papers where the significance is real but buried under jargon
If You Get Past the Desk
Clearing the desk dramatically changes your odds. Of the ~10% that make it to peer review, roughly 40-50% are eventually published. That's a much more encouraging number.
Nature typically sends papers to 2-3 reviewers. The review process is fast (often 2-4 weeks for reviews to come back). Nature's professional editors coordinate the process and make the final decision, weighing reviewer reports against their assessment of significance and impact.
What reviewers evaluate:
- Technical validity of the methods and conclusions
- Whether the significance claim holds up under scrutiny
- Novelty relative to the existing literature
- Reproducibility and reliability of key findings
- Quality of presentation and data visualization
Nature's Scope
Nature publishes across all natural sciences, but submission patterns cluster in certain areas:
Field | Submission Share | Competitiveness |
|---|---|---|
Biomedical/Life Sciences | ~50% | Highest competition |
Physical Sciences | ~20% | Moderate competition |
Earth/Environmental Sciences | ~15% | Moderate competition |
Technology/Engineering | ~10% | Lower competition |
Mathematics/Computing | ~5% | Lower volume, niche |
The practical implication: biomedical researchers face the toughest odds because that's where most submissions come from. A groundbreaking physics or earth sciences paper may have an easier path.
Nature vs the Nature Family
Nature's rejection doesn't have to be the end. The Nature family includes dozens of journals that cover specific fields at high impact:
Journal | IF | Scope |
|---|---|---|
Nature Medicine | 50.0 | Translational clinical research |
Nature Cell Biology | 17.3 | Cell biology mechanisms |
Nature Genetics | 27.5 | Genetics and genomics |
Nature Immunology | 25.2 | Immunology |
Nature Methods | 33.2 | Methods and tools |
15.7 | All natural sciences, broader acceptance |
Transfer system: When Nature rejects your paper, the editor may suggest a specific Nature family journal. If the editorial assessment transfers, the receiving journal can expedite its evaluation. Nature Communications is the most common transfer destination and has a ~20% acceptance rate.
Practical Submission Tips
- Presubmission inquiry. Nature accepts brief inquiries that let editors assess fit before you prepare a full submission. Use them. A positive response doesn't guarantee acceptance, but a negative one saves you months.
- The cover letter is critical. This is where you make the case for broad significance. Don't describe your methods. Describe why this matters to scientists outside your field.
- Write for accessibility. The introduction and abstract should be understandable to any scientist, not just specialists. Avoid jargon in the first paragraph.
- Figures are your story. Nature papers live or die on figure quality. The figures should tell the complete story even without reading the text.
- Be realistic about significance. Ask yourself honestly: would this paper be discussed at a faculty lunch table where physicists, biologists, and chemists are all present? If not, consider a Nature family journal instead.
- Timing matters. Submit when your field is "hot." Nature editors track scientific conversations and are more receptive to topics generating active debate.
Nature vs Other Top Journals
Journal | IF | When to Choose It Over Nature |
|---|---|---|
42.5 | Deep mechanistic biology with multiple validation approaches | |
45.8 | Equally broad, but sometimes faster for certain fields | |
50.0 | Translational work with clinical relevance | |
78.5 | Practice-changing clinical trials | |
88.5 | Global health clinical research |
The Impact Factor Context
Nature's IF of 48.5 is actually lower than Nature Medicine (50.0), NEJM (78.5), and Lancet (88.5). This reflects citation patterns: clinical and translational papers get cited more heavily than basic science papers because the biomedical literature is larger. Nature's prestige comes from its scope and selectivity, not its IF ranking.
More Resources
Free scan in about 60 seconds.
Run a free readiness scan before you submit.
More Articles
Want the full picture on Nature?
Anthropic Privacy Partner - zero retention